Clinical Pharmacokinetics of Quetiapine
Data up to Jan 2025
Total Citations Per Year
Abstract
References (26)
Clinical pharmacokinetics; concepts and applications
1989 • 2,266 citations
Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo
1997 • 756 citations
Quetiapine in Patients With Schizophrenia
1997 • 487 citations
Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes.
1990 • 423 citations
A Positron Emission Tomography Study of Quetiapine in Schizophrenia: A Preliminary Finding of an Antipsychotic Effect With Only Transiently High Dopamine D2 Receptor Occupancy
2000 • 401 citations
Age and cytochrome P450-linked drug metabolism in humans: An analysis of 226 subjects with equal histopathologic conditions*
1997 • 400 citations
A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia
1997 • 253 citations
Metabolic Drug Interactions
2000 • 208 citations
Pharmacokinetic Interactions of Cimetidine 1987
1987 • 195 citations
Time course of central nervous dopamine-D 2 and 5-HT 2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel ® ) in patients with schizophrenia
1998 • 167 citations
Pharmacokinetics, Tolerability, and Clinical Effectiveness of Quetiapine Fumarate
2000 • 137 citations
ICI 204,636, a novel, atypical antipsychotic: early indication of safety and efficacy in patients with chronic and subchronic schizophrenia
1995 • 92 citations
N-demethylation of amitriptyline in vitro: role of cytochrome P-450 3A (CYP3A) isoforms and effect of metabolic inhibitors.
1995 • 89 citations
The Effects of Concomitant Phenytoin Administration on the Steady-State Pharmacokinetics of Quetiapine
2001 • 75 citations
Prediction of the outcome of a phase 3 clinical trial of an antischizophrenic agent (quetiapine fumarate) by simulation with a population pharmacokinetic and pharmacodynamic model
2000 • 70 citations
A comparison of bd and tid dose regimens of quetiapine (Seroquel) in the treatment of schizophrenia
1998 • 70 citations
The Safety and Pharmacokinetics of Quetiapine When Coadministered With Haloperidol, Risperidone, or Thioridazine
2002 • 68 citations
[Cyclosporin A: drug interactions].
1991 • 67 citations
Single-dose pharmacokinetics of quetiapine in subjects with renal or hepatic impairment
2000 • 59 citations
ICI 204,636 (SEROQUEL™): A Dibenzothiazepine Atypical Antipsychotic. Review of Preclinical Pharmacology and Highlights of Phase II Clinical Trials
1995 • 51 citations
Effect of Fluoxetine and Imipramine on the Pharmacokinetics and Tolerability of the Antipsychotic Quetiapine
2002 • 43 citations
Determination of an antipsychotic agent (ICI 204,636) and its 7-hydroxy metabolite in human plasma by high-performance liquid chromatography and gas chromatography—mass spectrometry
1992 • 28 citations
NEW ANTIDEPRESSANT DRUGS AND THE TREATMENT OF DEPRESSION IN THE MEDICALLY ILL PATIENT
1996 • 25 citations
The Effect of Multiple Doses of Cimetidine on the Steady-State Pharmacokinetics of Quetiapine in Men With Selected Psychotic Disorders
2002 • 20 citations
The effect of zileuton on antipyrine and indocyanine green disposition*
1995 • 12 citations
Pharmacokinetics and safety of lithium co-administered with ‘seroquel’ (quetiapine)
1997 • 9 citations